These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


361 related items for PubMed ID: 29990842

  • 1. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.
    Gao J, Wang W, Wang F, Guo C.
    Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842
    [Abstract] [Full Text] [Related]

  • 2. LncRNA NEAT1 accelerates the occurrence and development of diabetic nephropathy by sponging miR-23c.
    Li N, Jia T, Li YR.
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1325-1337. PubMed ID: 32096162
    [Abstract] [Full Text] [Related]

  • 3. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
    Wang X, Xu Y, Zhu YC, Wang YK, Li J, Li XY, Ji T, Bai SJ.
    J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
    [Abstract] [Full Text] [Related]

  • 4. Sp1-Induced lncRNA Rmrp Promotes Mesangial Cell Proliferation and Fibrosis in Diabetic Nephropathy by Modulating the miR-1a-3p/JunD Pathway.
    Yang H, Wang J, Zhang Z, Peng R, Lv D, Liu H, Sun Y.
    Front Endocrinol (Lausanne); 2021 Aug; 12():690784. PubMed ID: 34512545
    [Abstract] [Full Text] [Related]

  • 5. The Long Noncoding RNA 150Rik Promotes Mesangial Cell Proliferation via miR-451/IGF1R/p38 MAPK Signaling in Diabetic Nephropathy.
    Zhang Y, Sun Y, Peng R, Liu H, He W, Zhang L, Peng H, Zhang Z.
    Cell Physiol Biochem; 2018 Aug; 51(3):1410-1428. PubMed ID: 30485837
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
    Liu B, Qiang L, Wang GD, Duan Q, Liu J.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
    Meng Q, Zhai X, Yuan Y, Ji Q, Zhang P.
    Braz J Med Biol Res; 2020 Apr; 53(4):e9288. PubMed ID: 32294702
    [Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
    Duan LJ, Ding M, Hou LJ, Cui YT, Li CJ, Yu DM.
    Biochem Biophys Res Commun; 2017 Mar 11; 484(3):598-604. PubMed ID: 28137588
    [Abstract] [Full Text] [Related]

  • 12. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY, Gao YB, Zhang N, Zou DW, Wang P, Zhu ZY, Li JY, Zhou SN, Wang SC, Wang YY, Yang JK.
    Mol Cell Endocrinol; 2014 Jul 05; 392(1-2):163-72. PubMed ID: 24887517
    [Abstract] [Full Text] [Related]

  • 13. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
    Gao BH, Wu H, Wang X, Ji LL, Chen C.
    Eur Rev Med Pharmacol Sci; 2020 Feb 05; 24(3):1338-1349. PubMed ID: 32096183
    [Abstract] [Full Text] [Related]

  • 14. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
    Yang J, Shen Y, Yang X, Long Y, Chen S, Lin X, Dong R, Yuan J.
    Am J Physiol Renal Physiol; 2019 Nov 01; 317(5):F1350-F1358. PubMed ID: 31545928
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
    Shen Y, Tong ZW, Zhou Y, Sun Y, Xie Y, Li R, Liu H.
    Eur Rev Med Pharmacol Sci; 2020 Jun 01; 24(12):6864-6872. PubMed ID: 32633379
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1.
    Ma J, Zhang L, Hao J, Li N, Tang J, Hao L.
    J Pharmacol Sci; 2018 Apr 01; 136(4):218-227. PubMed ID: 29551286
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA NEAT1 inhibits high glucose-induced EMT and renal fibrogenesis in Human Embryonic Kidney 293 cells via regulating miR-204/SOX4 axis.
    Ahmad Wadaan M, Ahmad M, Hussein Hamzah I.
    Cell Mol Biol (Noisy-le-grand); 2023 Oct 31; 69(10):189-194. PubMed ID: 37953563
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
    Yu D, Yang X, Zhu Y, Xu F, Zhang H, Qiu Z.
    Endocr J; 2021 May 28; 68(5):519-529. PubMed ID: 33408314
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.